Overcoming the Business Challenges of Rare Diseases

Thought Leader:

Michael Carlin, Vice President, TrialCard

July 28, 2016

In this episode, Michael Carlin of TrialCard discusses rare diseases and orphan drugs, and how life sciences companies can overcome the many business challenges associated with these types of disease states.

There is also a related white paper entitled “No Patient Left Behind – Connecting Rare Disease Patients to Orphan Drug Manufacturers.” Use the download link below.

Length: 10:09       Size: 4.6MB

Post a Comment

You must be logged in to post a Comment.